13F-HR filed by Finepoint Capital LP
Finepoint Capital LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 44 holding rows worth $309,294,000.
- Accession
- 0001567619-23-002450
- Filer
- CIK 1608126
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 44 entries on the cover page, a total value of $309,294,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $309,293,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,026,300 | $21,583,000 | thousands, detected and multiplied | |
| ALGOMA STL GROUP INC | 015658107 | COM | 3,219,441 | $20,411,000 | thousands, detected and multiplied | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 322,900 | $19,455,000 | thousands, detected and multiplied | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,176,830 | $18,735,000 | thousands, detected and multiplied | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 402,793 | $18,456,000 | thousands, detected and multiplied | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,428,475 | $17,442,000 | thousands, detected and multiplied | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 390,359 | $17,324,000 | thousands, detected and multiplied | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 334,890 | $17,317,000 | thousands, detected and multiplied | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 131,457 | $17,034,000 | thousands, detected and multiplied | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 643,000 | $16,724,000 | thousands, detected and multiplied | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 134,036 | $16,370,000 | thousands, detected and multiplied | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 517,287 | $16,315,000 | thousands, detected and multiplied | |
| IVERIC BIO INC | 46583P102 | COM | 707,600 | $15,150,000 | thousands, detected and multiplied | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 822,745 | $15,056,000 | thousands, detected and multiplied | |
| ARVINAS INC | 04335A105 | COM | 429,600 | $14,697,000 | thousands, detected and multiplied | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 381,765 | $14,561,000 | thousands, detected and multiplied | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 714,848 | $10,680,000 | thousands, detected and multiplied | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,545,589 | $9,876,000 | thousands, detected and multiplied | |
| DISH NETWORK CORPORATION | 25470MAF6 | NOTE 12/1 | 15,000,000 | $9,645,000 | thousands, detected and multiplied | principal |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 218,562 | $1,176,000 | thousands, detected and multiplied | |
| ARES ACQUISITION CORPORATION | G33032122 | *W EXP 02/02/202 | 504,706 | $235,000 | thousands, detected and multiplied | |
| SUMMIT HEALTHCRE ACQUISTN CO | G8566R110 | *W EXP 06/03/202 | 489,999 | $139,000 | thousands, detected and multiplied | |
| CORSAIR PARTNERING CORP | G2540H116 | *W EXP 07/06/202 | 334,666 | $110,000 | thousands, detected and multiplied | |
| BRIDGETOWN HOLDINGS LTD | G1355U121 | *W EXP 09/30/202 | 895,000 | $103,000 | thousands, detected and multiplied | |
| CONYERS PARK III ACQSITN COR | 21289P110 | *W EXP 08/12/202 | 571,666 | $85,000 | thousands, detected and multiplied | |
| ZIMMER ENERGY TRANSITION ACQ | 989570114 | *W EXP 06/16/202 | 358,270 | $68,000 | thousands, detected and multiplied | |
| JAWS HURRICANE ACQUISITN COR | 47201B111 | *W EXP 03/26/202 | 387,249 | $62,000 | thousands, detected and multiplied | |
| SENIOR CONNECT ACQUISITN COR | 81723H116 | *W EXP 12/31/202 | 1,014,000 | $61,000 | thousands, detected and multiplied | |
| CHURCHILL CAPITAL CORP V | 17144T115 | *W EXP 10/29/202 | 612,000 | $49,000 | thousands, detected and multiplied | |
| CONCORD ACQUISITION II CORP | 20607u116 | WT | 408,333 | $47,000 | thousands, detected and multiplied | |
| COMPASS DIGITAL ACQUISITION CO | g2476c123 | WT | 459,906 | $37,000 | thousands, detected and multiplied | |
| SWIFTMERGE ACQUISITION CORP | G63836111 | *W EXP 12/13/202 | 490,000 | $36,000 | thousands, detected and multiplied | |
| CALIDI BIOTHERAPEUTICS INC | 320703119 | *W EXP 03/14/202 | 655,200 | $33,000 | thousands, detected and multiplied | |
| BILANDER ACQUISITION CORP | 09001T114 | *W EXP 05/19/202 | 183,749 | $33,000 | thousands, detected and multiplied | |
| CHURCHILL CAPITAL CORP VI | 17143W119 | *W EXP 02/17/202 | 540,000 | $32,000 | thousands, detected and multiplied | |
| BERENSON ACQUISITION CORP I | 083690115 | *W EXP 08/01/202 | 862,499 | $31,000 | thousands, detected and multiplied | |
| MARBLEGATE ACQUISITION CORP | 56608A113 | *W EXP 08/31/202 | 735,000 | $29,000 | thousands, detected and multiplied | |
| AFTERNEXT HEALTHTECH ACQUISI | G01109126 | *W EXP 99/99/999 | 366,666 | $28,000 | thousands, detected and multiplied | |
| CHURCHILL CAPITAL CORP VII | 17144M110 | *W EXP 02/29/202 | 548,000 | $27,000 | thousands, detected and multiplied | |
| ROSS ACQUISITION II CORP | g7641c114 | WT | 439,666 | $22,000 | thousands, detected and multiplied | |
| HOME PLATE ACQUISITION CORP | 43734R111 | *W EXP 09/30/202 | 690,000 | $7,000 | thousands, detected and multiplied | |
| SKYDECK ACQUISITION CORP | G82220115 | *W EXP 05/13/202 | 361,756 | $7,000 | thousands, detected and multiplied | |
| LEVERE HOLDINGS CORP | G5462L122 | *W EXP 03/09/202 | 274,999 | $4,000 | thousands, detected and multiplied | |
| CATALYST PARTNRS ACQUISITN C | G19550121 | *W EXP 05/12/202 | 336,666 | $1,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-23-002450 | this filing | 2023-02-13 | acceptance time not in the bulk data set |